Literature DB >> 11418634

Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells.

H J Garbán1, B Bonavida.   

Abstract

NO has been increasingly implicated in control of the transcriptional machinery and serves as an intracellular second messenger to modify gene expression. We have demonstrated that NO up-regulated Fas receptor expression in ovarian carcinoma cell lines, albeit the mechanism involved is not known. Thus, we hypothesized that NO, directly or indirectly, may modify the transcriptional machinery that is responsible for the increased expression of the Fas gene. We examined the effect of NO on Fas gene expression using a Fas promoter-driven luciferase reporter system. Transient transfection of AD10 cells with pGL-3-FasP demonstrated that the IFN-gamma-dependent NO generation increases the trans-activation of the Fas promoter, and this increase was blocked by the NOS inhibitor (N(G)-monomethyl-L-arginine), but could be restored by the addition of the NO donor S-nitroso-N-acetylpenicillamine. Systematic deletion of the Fas promoter revealed that the functional region responsible for the NO-mediated effect was located at the silencer region, suggesting that NO may be responsible for the disruption of a repressor mechanism. We demonstrate that NO up-regulates the expression of the Fas receptor on AD10 cells via the specific inactivation of the transcription repressor yin-yang 1 DNA binding activity to the silencer region of the Fas promoter. These findings reveal a new mechanism of NO-mediated gene regulation by interfering with a repressor transcription factor at the silencer region of the Fas promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418634     DOI: 10.4049/jimmunol.167.1.75

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  What signals are generated by anti-CD20 antibody therapy?

Authors:  Benjamin Bonavida
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

3.  Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

Review 4.  Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide.

Authors:  Andrea Predonzani; Bianca Calì; Andrielly Hr Agnellini; Barbara Molon
Journal:  World J Exp Med       Date:  2015-05-20

Review 5.  Nitrosothiol signaling and protein nitrosation in cell death.

Authors:  Anand Krishnan V Iyer; Yon Rojanasakul; Neelam Azad
Journal:  Nitric Oxide       Date:  2014-07-23       Impact factor: 4.427

Review 6.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

7.  Transcription regulator Yin-yang 1: from silence to cancer.

Authors:  Weidong Zhu; Samuel Y Olson; Hermes Garbán
Journal:  Crit Rev Oncog       Date:  2011

8.  Phosphorylation of the transcription factor YY1 by CK2α prevents cleavage by caspase 7 during apoptosis.

Authors:  Sarah Riman; Raed Rizkallah; Ari Kassardjian; Karen E Alexander; Bernhard Lüscher; Myra M Hurt
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

9.  S-nitrosylation in the regulation of gene transcription.

Authors:  Yonggang Sha; Harvey E Marshall
Journal:  Biochim Biophys Acta       Date:  2011-05-24

Review 10.  Neomorphic mutations create therapeutic challenges in cancer.

Authors:  V Takiar; C K M Ip; M Gao; G B Mills; L W T Cheung
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.